Wealth Enhancement Advisory Services
NBIX icon

Wealth Enhancement Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
71,595
-8,694
-11% -$1.29M 0.02% 627
2026
Q1 		$9.34M Buy
80,289
+25,896
+48% +$3.44M 0.02% 614
2025
Q4 		$7.49M Buy
54,393
+13,534
+33% +$1.96M 0.01% 820
2025
Q3 		$5.6M Buy
40,859
+21,752
+114% +$2.95M 0.01% 895
2025
Q2 		$2.47M Buy
19,107
+13,301
+229% +$1.53M ﹤0.01% 1250
2025
Q1 		$642K Sell
5,806
-11,080
-66% -$1.4M ﹤0.01% 1869
2024
Q4 		$2.3M Buy
16,886
+11,240
+199% +$1.39M ﹤0.01% 1109
2024
Q3 		$651K Sell
5,646
-711
-11% -$97.5K ﹤0.01% 1641
2024
Q2 		$875K Buy
6,357
+1,613
+34% +$221K ﹤0.01% 1343
2024
Q1 		$654K Buy
4,744
+1,550
+49% +$212K ﹤0.01% 1439
2023
Q4 		$421K Buy
3,194
+316
+11% +$36.4K ﹤0.01% 1620
2023
Q3 		$324K Buy
+2,878
New +$303K ﹤0.01% 1695

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Wealth Enhancement Advisory Services's NBIX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Neurocrine Biosciences (NBIX) stake by 11% in Q2 2026, selling an estimated $1.29M and leaving 71,595 shares worth $11.2M. The position accounts for 0.02% of the portfolio, ranked #627.

Wealth Enhancement Advisory Services first reported a position in NBIX in Q3 2023 and has held it in 12 quarters since. 92 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 71,595 shares of Neurocrine Biosciences worth $11.2M as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 8,694 Neurocrine Biosciences shares in Q2 2026, an estimated $1.29M.
  • Neurocrine Biosciences made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #627 holding.
  • Wealth Enhancement Advisory Services first reported a position in Neurocrine Biosciences in Q3 2023 and has held it in 12 quarters since.
  • 92 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.